(Q57279306)
Statements
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 (English)
Patricia Pérez-Galán
Mónica López-Guerra
Laia Rosich
Ifigènia Saborit-Villarroya
Emmanuel Normant
24 November 2010